louisiana semaglutide gastric stasis class action glp-1 law office in firm west virginia Gastrointestinal Motility Effects of Receptor Agonists GLP-1 RA Lawsuit louisiana semaglutide gastric stasis class

6 Furthermore, a high-fat diet induces colon and intestinal tumorigenesis by promoting the proliferation of intestinal stem cells

The FDA announced the action on April 15, 2026 (Federal Register notice April 16), and the peptides come off the Category 2 list effective April 23, 2026

Because of the cardiorenal benefits of RAASis, if these medications must be temporarily reduced or withheld due to hyperkalemia, a retrial of RAASi should be considered, potentially at a lower dose once hyperkalemia is resolved

How GLP-1 Medications Work at Our Moreno Valley Clinic Our process emphasizes safety, clarity, and provider oversight for men in and around Moreno Valley